"[\n    {\n        \"_id\": {\n            \"DrugName\": \"PR-001\",\n            \"Indication\": \"Gauchers disease type III\"\n        },\n        \"lastUpdate\": \"2019-09-10T00:00:00\",\n        \"lastPhase\": \"Preclinical\"\n    },\n    {\n        \"_id\": {\n            \"DrugName\": \"PR-001\",\n            \"Indication\": \"Parkinsons disease\"\n        },\n        \"lastUpdate\": \"2019-10-15T00:00:00\",\n        \"lastPhase\": \"Phase 2 Clinical\"\n    },\n    {\n        \"_id\": {\n            \"DrugName\": \"PR-006\",\n            \"Indication\": \"Frontotemporal dementia\"\n        },\n        \"lastUpdate\": \"2019-05-24T00:00:00\",\n        \"lastPhase\": \"Preclinical\"\n    },\n    {\n        \"_id\": {\n            \"DrugName\": \"PR-004\",\n            \"Indication\": \"Neurodegenerative disease\"\n        },\n        \"lastUpdate\": \"2019-05-24T00:00:00\",\n        \"lastPhase\": \"Preclinical\"\n    },\n    {\n        \"_id\": {\n            \"DrugName\": \"PR-001\",\n            \"Indication\": \"Gauchers disease type II\"\n        },\n        \"lastUpdate\": \"2019-09-10T00:00:00\",\n        \"lastPhase\": \"Preclinical\"\n    }\n]"
